Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
-
2024 Annual General Meeting
-
Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference
-
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
-
Greenbacker delivers third quarter results
-
Jobvite Announces the Availability of LinkedIn CRM Connect Integration
-
Only 33% of Users Back Up Their Data Regularly - New Study From Handy Recovery Advisor
-
CORERO NETWORK SECURITY TAPS INDUSTRY VETERAN JUDSON THUERK TO LEAD CHANNEL STRATEGY IN THE AMERICAS
-
Hamilton Lane Global Private Assets Fund Honored with 2024 Canadian Hedge Fund Award for Three-Year Returns Among Private Equity Offerings
-
McDermott Achieves ISO 50001 Certification for Energy Management at Four Fabrication Yards
-
LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System
-
Catalyst Bancorp, Inc. Announces New Share Repurchase Plan
-
VINCI COMPASS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION TODAY AT 8:00AM ET
-
American Battery Solutions Powers Marine Travelift's New Electric Series Boat Hoists
-
Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
-
KHLOÉ KARDASHIAN DEBUTS FIRST-EVER SIGNATURE FRAGRANCE WITH LUXE BRANDS
-
Opthea to Participate in Citi 2024 Global Healthcare Conference
-
Kanglin Biotechnology Announces $20 Million Series A Financing to Advance the Development of Gene Therapies
-
EmergeOrtho-Triangle Region Welcomes Joseph Massaglia Jr., D.O.
-
HORIZON PETROLEUM ANNOUNCES REINSTATEMENT AS A TIER 2 ISSUER ONTO THE TSX VENTURE EXCHANGE
-
NHOA : Implementation of the Compulsory Buyout of the Company's Shares
-
Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Elida Beauty Conditions its Supply Chain for Success with Kinaxis
-
POET Expands Capacity to Meet AI Infrastructure Demand
-
Strategic Resources Signs High Purity Iron Ore Supply and Offtake Agreements with Javelin Global Commodities along with a US$150 Million Working Capital Facility
-
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
-
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine Demonstrating Early Detection of Patient Deterioration with FDA-cleared BioButton® Continuous Monitoring Wearable Device
-
Honoring Paula Gallant: New Book Advocates for Change and Raises Awareness on Violence Against Women
-
Mobix Labs Announces Strategic Acquisition of Spacecraft Components
-
Semler Scientific® Announces Updated BTC and ATM Activity
-
Mubadala Capital to Take CI Financial Private via Premium, All-Cash Offer
-
TRUQAP® (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progress
-
Entrepreneur names four BELFOR Franchise Group brands on 2024 list of top franchises for Veterans
-
Shorla Oncology Announces FDA Approval of IMKELDI (imatinib) Oral Solution, an Oral Liquid for the Treatment of Certain Forms of Leukemia and Other Cancers
-
Rocket Lab Signs $23.9M CHIPS Incentives Award to Boost Semiconductor Manufacturing
-
Corsair Gaming to Present at Barclays 22nd Annual Global Technology Conference
-
D-Wave Names Sharon Holt to Board of Directors
-
STAAR Surgical to Participate in BTIG Ophthalmology Day
-
Swvl Secures Sustainable Finance with HSBC to Finance New Client Contracts
-
Bybit and DMCC Crowned 5 Blockchain Projects in MENA’s Largest Web3 Hackathon
-
ATHA Energy Announces Assay Results From 2024 Angilak Exploration Program Including Intersect Grades Up to 5.85% U3O8 and Releases Exploration Target Model for the Lac 50 Deposit
-
GURU Organic Energy Announces Transition from Distribution Agreement with PepsiCo Canada
-
Shattuck Labs Announces Participation in Upcoming December Conferences
-
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
-
U-BX Technology Ltd. Announces Effective Date of Reverse Stock Split
-
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
-
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
-
Brightstar Capital Partners Announces Hiring of Charles Yoon, Industry Veteran with Extensive Experience Investing in Lower Middle Market
-
Brightstar Capital Partners Announces Hiring of Charles Yoon, Industry Veteran with Extensive Experience Investing in Lower Middle Market

